
Sagar S. Patel
Examiner (ID: 4771, Phone: (571)272-1317 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 632 |
| Issued Applications | 425 |
| Pending Applications | 71 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18244509
[patent_doc_number] => 20230076820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative Diseases
[patent_app_type] => utility
[patent_app_number] => 17/741153
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741153 | Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative Diseases | May 9, 2022 | Abandoned |
Array
(
[id] => 17855583
[patent_doc_number] => 20220285626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/739737
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739737 | Spirobifluorene compounds for organic electroluminescent devices | May 8, 2022 | Issued |
Array
(
[id] => 19299938
[patent_doc_number] => 20240228507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => GREEN SOLVENTS FOR CHEMICAL REACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/287063
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287063
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287063 | GREEN SOLVENTS FOR CHEMICAL REACTIONS | Apr 13, 2022 | Pending |
Array
(
[id] => 18215224
[patent_doc_number] => 11590137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Ruxolitinib formulation for reduction of itch in atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 17/705624
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 48772
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705624 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Mar 27, 2022 | Issued |
Array
(
[id] => 17720294
[patent_doc_number] => 20220213014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL
[patent_app_type] => utility
[patent_app_number] => 17/702894
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702894 | CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL | Mar 23, 2022 | Abandoned |
Array
(
[id] => 19246682
[patent_doc_number] => 20240197666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)
[patent_app_type] => utility
[patent_app_number] => 18/283787
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -132
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283787 | DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) | Mar 22, 2022 | Pending |
Array
(
[id] => 17704528
[patent_doc_number] => 20220204534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => APPARATUS AND CONTINUOUS FLOW PROCESS FOR PRODUCTION OF BORONIC ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/698719
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698719 | APPARATUS AND CONTINUOUS FLOW PROCESS FOR PRODUCTION OF BORONIC ACID DERIVATIVE | Mar 17, 2022 | Abandoned |
Array
(
[id] => 17960033
[patent_doc_number] => 20220340613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/697247
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697247 | CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE | Mar 16, 2022 | Abandoned |
Array
(
[id] => 17829948
[patent_doc_number] => 20220267252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MESCALINE DERIVATIVES WITH MODIFIED ACTION
[patent_app_type] => utility
[patent_app_number] => 17/676169
[patent_app_country] => US
[patent_app_date] => 2022-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676169 | MESCALINE DERIVATIVES WITH MODIFIED ACTION | Feb 19, 2022 | Abandoned |
Array
(
[id] => 17627142
[patent_doc_number] => 20220162157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => BENZYLAMINO-OXOETHYL BENZAMIDE ANALOGS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/666692
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/666692 | Benzylamino-oxoethyl benzamide analogs and methods of use | Feb 7, 2022 | Issued |
Array
(
[id] => 19032433
[patent_doc_number] => 20240082248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => PROCESS FOR PREPARATION OF MAVACAMTEN AND SOLID STATE FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/275284
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275284 | PROCESS FOR PREPARATION OF MAVACAMTEN AND SOLID STATE FORMS THEREOF | Jan 30, 2022 | Pending |
Array
(
[id] => 20644650
[patent_doc_number] => 12599575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/275475
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275475
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275475 | Antimicrobial adjuvant containing biphenyl derivative compound as active ingredient, and uses thereof | Jan 27, 2022 | Issued |
Array
(
[id] => 19432427
[patent_doc_number] => 20240300925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => TETRAHYDROPYRROLOCYCLIC COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/275251
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275251 | Tetrahydropyrrolocyclic compound and application thereof | Jan 26, 2022 | Issued |
Array
(
[id] => 19462376
[patent_doc_number] => 20240316045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH
[patent_app_type] => utility
[patent_app_number] => 18/263227
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263227
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263227 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | Jan 25, 2022 | Pending |
Array
(
[id] => 19125693
[patent_doc_number] => 20240131046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => ANTI-VIRAL AGENT
[patent_app_type] => utility
[patent_app_number] => 18/262326
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262326
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262326 | ANTI-VIRAL AGENT | Jan 19, 2022 | Pending |
Array
(
[id] => 17790603
[patent_doc_number] => 20220249694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NANOMATERIALS COMPRISING A BIODEGRADABLE FEATURE
[patent_app_type] => utility
[patent_app_number] => 17/579150
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579150 | Nanomaterials comprising a biodegradable feature | Jan 18, 2022 | Issued |
Array
(
[id] => 19477318
[patent_doc_number] => 20240325360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => THERAPEUTIC METHODS USING VADADUSTAT
[patent_app_type] => utility
[patent_app_number] => 18/259897
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -103
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259897
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259897 | THERAPEUTIC METHODS USING VADADUSTAT | Jan 6, 2022 | Pending |
Array
(
[id] => 17561648
[patent_doc_number] => 20220125797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/570299
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570299 | SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | Jan 5, 2022 | Abandoned |
Array
(
[id] => 17837656
[patent_doc_number] => 20220274961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/560545
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560545 | SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS | Dec 22, 2021 | Abandoned |
Array
(
[id] => 17520448
[patent_doc_number] => 20220106297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PHOTOPROTECTIVE COMPOSITIONS CONTAINING MALASSEZIA-DERIVED COMPOUNDS AND/OR CHEMICAL ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/554725
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554725 | Photoprotective compositions containing | Dec 16, 2021 | Issued |